← FDA DRUG APPROVALS

FDA ANDA · ANDA076043

TERCONAZOLE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA076043
TYPE
ANDA
ORIGINAL APPROVAL
2005-01-19
LATEST ACTION
2015-08-20
ROUTE
VAGINAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

TERCONAZOLEPrescription
TERCONAZOLE 0.4% · CREAM · VAGINAL

Approval history

2015-08-20Labeling · Supplement 8 · standardAP
2015-08-20Labeling · Supplement 9 · standardAP
2005-01-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →